InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GMF | Ann: Removal from Official List-1 Nov 2016-GMF.AX | 01/11/16 | 0 | 274 | |||
|
|||||||
GMF | Ann: Completion of compulsory acquisition of GMF units,GMF-GOZ.AX | 31/10/16 | 0 | 180 | |||
|
|||||||
GMF | Ann: Suspension from Official Quotation at COT 30/09/2016-GMF.AX | 30/09/16 | 0 | 189 | |||
|
|||||||
GMF | Ann: Minority Facility Documentation,GMF-GOZ.AX | 29/09/16 | 0 | 203 | |||
|
|||||||
GMF | Ann: Result of Extraordinary General Meeting,GOZ-GMF.AX | 27/09/16 | 0 | 168 | |||
|
|||||||
GMF | Ann: Compulsory acquisition of GMF and reminder of close,GOZ-GMF.AX | 23/09/16 | 0 | 169 | |||
|
|||||||
GMF | Ann: Distribution for the Quarter Ending September 2016-GMF.AX | 23/09/16 | 0 | 101 | |||
|
|||||||
GMF | Ann: Dividend/Distribution - GMF-GMF.AX | 23/09/16 | 0 | 95 | |||
|
See All Discussions